Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for David Thomas Evans. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at David Thomas Evans har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:CDLX / Cardlytics, Inc. Chief Administrative Officer 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av David Thomas Evans. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp CDLX / Cardlytics, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
2018-02-13 CDLX Evans David Thomas 1 500 13,0000 1 500 13,0000 19 500 216 27.6500 21 975 112,69

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

CDLX / Cardlytics, Inc. Insider Trades
Internhandel CDLX / Cardlytics, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
2020-08-27 CDLX Evans David Thomas 2 502 80,1000 2 502 80,1000 200 410 21 64.2550 −39 644 −19,78
2020-08-27 CDLX Evans David Thomas 1 049 80,8100 1 049 80,8100 84 770
2020-08-27 CDLX Evans David Thomas 1 432 81,7000 1 432 81,7000 116 994
2020-08-13 CDLX Evans David Thomas 86 79,6200 86 79,6200 6 847
2020-08-12 CDLX Evans David Thomas 15 047 77,1400 15 047 77,1400 1 160 726
2020-08-11 CDLX Evans David Thomas 13 019 75,5500 13 019 75,5500 983 585
2020-08-11 CDLX Evans David Thomas 401 76,0500 401 76,0500 30 496
2020-05-27 CDLX Evans David Thomas 4 512 66,9800 4 512 66,9800 302 214
2020-05-25 CDLX Evans David Thomas 700 67,4800 700 67,4800 47 236
2020-05-21 CDLX Evans David Thomas 150 67,7712 150 67,7712 10 166
2020-03-09 CDLX Evans David Thomas 5 046 44,4800 5 046 44,4800 224 446
2020-03-09 CDLX Evans David Thomas 800 45,4600 800 45,4600 36 368
2019-11-26 CDLX Evans David Thomas 14 741 55,8800 14 741 55,8800 823 727
2019-11-26 CDLX Evans David Thomas 6 540 56,2000 6 540 56,2000 367 548
2018-12-11 CDLX Evans David Thomas 14 047 13,3300 14 047 13,3300 187 247
2018-12-10 CDLX Evans David Thomas 13 100 13,6900 13 100 13,6900 179 339
2018-08-17 CDLX Evans David Thomas 1 198 20,6600 1 198 20,6600 24 751

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

CDLX / Cardlytics, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av David Thomas Evans som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2020-10-06 2020-09-30 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −10 937 0 −100,00
2020-10-06 2020-09-30 4 CDLX Cardlytics, Inc.
Restricted Stock Unit
M - Exercise −87 500 0 −100,00
2020-10-06 2020-09-30 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 10 937 106 013 11,50
2020-10-06 2020-09-30 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 87 500 95 076 1 154,96
2020-08-28 2020-08-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −1 432 7 576 −15,90 81,70 −116 994 618 959
2020-08-28 2020-08-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −1 049 9 008 −10,43 80,81 −84 770 727 936
2020-08-28 2020-08-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −2 502 10 057 −19,92 80,10 −200 410 805 566
2020-08-28 2020-08-26 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −10 937 10 937 −50,00
2020-08-28 2020-08-26 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 10 937 12 559 674,29
2020-08-13 2020-08-13 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −86 1 622 −5,04 79,62 −6 847 129 144
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −4 769 3 125 −60,41
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −4 769 3 125 −60,41
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −5 509 0 −100,00
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −15 047 1 708 −89,81 77,14 −1 160 726 131 755
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 4 769 16 755 39,79 20,00 95 380 335 100
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 4 769 11 986 66,08 30,44 145 168 364 854
2020-08-13 2020-08-12 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 5 509 7 217 322,54 20,00 110 180 144 340
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −700 7 894 −8,15
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −700 7 894 −8,15
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −741 5 509 −11,86
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Restricted Stock Units
M - Exercise −208 0 −100,00
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Restricted Stock Units
A - Award 208 208
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −401 1 708 −19,01 76,05 −30 496 129 893
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −13 019 2 109 −86,06 75,55 −983 585 159 335
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 700 15 128 4,85 20,00 14 000 302 560
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 700 14 428 5,10 30,44 21 308 439 188
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 741 13 728 5,71 20,00 14 820 274 560
2020-08-13 2020-08-11 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 208 12 987 1,63
2020-05-27 2020-05-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −4 512 13 479 −25,08 66,98 −302 214 902 823
2020-05-27 2020-05-25 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −10 938 21 874 −33,34
2020-05-27 2020-05-25 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −700 12 779 −5,19 67,48 −47 236 862 327
2020-05-27 2020-05-25 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 10 938 17 991 155,08
2020-05-22 2020-05-21 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −150 7 053 −2,08 67,77 −10 166 477 990
2020-05-22 2020-05-20 4 CDLX Cardlytics, Inc.
Restricted Stock Units
M - Exercise −355 0 −100,00
2020-05-22 2020-05-20 4 CDLX Cardlytics, Inc.
Restricted Stock Units
A - Award 355 355
2020-05-22 2020-05-20 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 355 7 203 5,18
2020-03-11 2020-03-09 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −800 6 592 −10,82 45,46 −36 368 299 672
2020-03-11 2020-03-09 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −5 046 7 392 −40,57 44,48 −224 446 328 796
2020-03-04 2020-03-04 4 CDLX Cardlytics, Inc.
Restricted Stock Unit
A - Award 87 500 87 500
2020-03-04 2020-03-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −4 310 12 438 −25,73 78,80 −339 628 980 114
2020-03-02 2020-02-26 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −10 938 32 812 −25,00
2020-03-02 2020-02-26 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 10 938 16 748 188,26
2020-02-18 2020-02-18 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −3 000 5 810 −34,05 98,12 −294 360 570 077
2020-02-04 2020-02-03 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −17 574 8 810 −66,61 84,71 −1 488 694 746 295
2020-02-04 2020-02-03 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −4 426 26 384 −14,37 83,89 −371 297 2 213 354
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −25 781 11 719 −68,75
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −28 906 8 594 −77,08
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −53 757 6 250 −89,58
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −5 777 30 810 −15,79 87,68 −506 527 2 701 421
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −9 937 36 587 −21,36 86,97 −864 221 3 181 971
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −24 635 46 524 −34,62 85,80 −2 113 683 3 991 759
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −30 425 71 159 −29,95 85,06 −2 587 950 6 052 785
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −29 096 101 584 −22,27 83,99 −2 443 773 8 532 040
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 25 781 130 680 24,58 30,44 784 774 3 977 899
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 28 906 104 899 38,04 20,00 578 120 2 097 980
2020-01-28 2020-01-27 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 53 757 75 993 241,76 20,00 1 075 140 1 519 860
2020-01-15 2020-01-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −3 000 22 236 −11,89 85,02 −255 060 1 890 505
2020-01-03 2020-01-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −600 25 236 −2,32 63,38 −38 028 1 599 458
2020-01-03 2020-01-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −2 665 25 836 −9,35 62,29 −166 003 1 609 324
2020-01-03 2020-01-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −12 115 28 501 −29,83 61,60 −746 284 1 755 662
2020-01-03 2020-01-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −6 620 40 616 −14,01 60,36 −399 583 2 451 582
2019-12-16 2019-12-16 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −3 000 47 236 −5,97 57,00 −171 000 2 692 452
2019-12-05 2019-12-03 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −2 586 50 236 −4,90 60,00 −155 160 3 014 160
2019-12-05 2019-12-02 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise −22 500 0 −100,00
2019-12-05 2019-12-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −2 414 52 822 −4,37 60,00 −144 840 3 169 320
2019-12-05 2019-12-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −17 000 55 236 −23,53 55,94 −950 980 3 089 902
2019-12-05 2019-12-02 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 22 500 72 236 45,24 9,08 204 300 655 903
2019-11-27 2019-11-26 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −6 540 49 034 −11,77 56,20 −367 548 2 755 711
2019-11-27 2019-11-26 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −14 741 55 574 −20,96 55,88 −823 727 3 105 475
2019-11-27 2019-11-25 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −21 875 43 750 −33,33
2019-11-27 2019-11-25 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −21 875 43 750 −33,33
2019-11-27 2019-11-25 4 CDLX Cardlytics, Inc.
Performance Stock Unit
A - Award 43 750 87 500 100,00
2019-11-27 2019-11-25 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 21 875 70 315 45,16
2019-11-27 2019-11-25 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 21 875 70 315 45,16
2019-11-15 2019-11-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −3 000 26 565 −10,15 57,12 −171 360 1 517 393
2019-11-15 2019-11-13 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −2 000 29 565 −6,34 47,65 −95 300 1 408 772
2019-11-15 2019-11-13 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −5 000 31 565 −13,67 50,00 −250 000 1 578 250
2019-11-15 2019-11-13 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −5 000 36 565 −12,03 55,00 −275 000 2 011 075
2019-11-01 2019-11-01 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −5 000 41 565 −10,74 41,26 −206 300 1 714 972
2019-10-30 2019-10-29 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −3 906 0 −100,00
2019-10-30 2019-10-29 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −6 906 46 565 −12,92 40,00 −276 240 1 862 600
2019-10-30 2019-10-29 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 3 906 53 471 7,88 20,00 78 120 1 069 420
2019-10-15 2019-10-15 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −31 962 3 906 −89,11
2019-10-15 2019-10-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −3 000 49 565 −5,71 37,15 −111 450 1 841 340
2019-10-15 2019-10-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −21 555 52 565 −29,08 37,50 −808 312 1 971 188
2019-10-15 2019-10-15 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 31 962 74 120 75,81 20,00 639 240 1 482 400
2019-10-15 2019-10-11 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X −1 631 35 868 −4,35
2019-10-15 2019-10-11 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 100 42 158 −2,54 37,50 −41 250 1 580 925
2019-10-15 2019-10-11 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise X 1 631 43 258 3,92 20,00 32 620 865 160
2019-10-03 2019-10-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −2 000 41 627 −4,58 35,00 −70 000 1 456 945
2019-08-28 2019-08-26 4 CDLX Cardlytics, Inc.
Performance Stock Unit
A - Award 43 750 43 750
2019-08-22 2019-08-22 4 CDLX Cardlytics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise 10 000 22 500 80,00
2019-08-22 2019-08-22 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 10 000 43 627 29,74 9,08 90 800 396 133
2019-08-19 2019-08-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 500 33 627 −4,27 33,93 −50 895 1 140 964
2019-07-15 2019-07-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 500 35 127 −4,10 28,14 −42 210 988 474
2019-06-19 2019-06-17 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 500 36 627 −3,93 25,18 −37 770 922 268
2019-05-17 2019-05-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 500 38 127 −3,79 19,99 −29 985 762 159
2019-04-17 2019-04-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −1 500 38 664 −3,73 15,42 −23 125 596 071
2019-03-29 2019-03-29 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −819 40 164 −2,00 16,52 −13 530 663 509
2019-03-29 2019-03-28 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −831 40 983 −1,99 16,30 −13 545 668 023
2019-03-29 2019-03-27 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −855 41 814 −2,00 15,84 −13 543 662 334
2019-03-26 2019-03-26 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −863 42 669 −1,98 15,68 −13 532 669 050
2019-03-26 2019-03-25 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −887 43 532 −2,00 15,26 −13 536 664 298
2019-03-26 2019-03-22 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −866 44 419 −1,91 15,65 −13 553 695 157
2019-03-21 2019-03-21 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −850 45 285 −1,84 15,92 −13 532 720 937
2019-03-21 2019-03-20 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −870 46 135 −1,85 15,56 −13 537 717 861
2019-03-21 2019-03-19 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −864 47 005 −1,80 15,68 −13 548 737 038
2019-03-18 2019-03-18 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −871 47 869 −1,79 15,54 −13 535 743 884
2019-03-18 2019-03-15 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −879 48 740 −1,77 15,39 −13 528 750 109
2019-03-18 2019-03-14 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −884 49 619 −1,75 15,32 −13 543 760 163
2019-03-13 2019-03-13 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −859 50 503 −1,67 15,75 −13 529 795 422
2019-03-13 2019-03-12 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −846 51 362 −1,62 15,99 −13 528 821 278
2019-03-13 2019-03-11 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale X −849 52 208 −1,60 15,95 −13 542 832 718
2018-12-12 2018-12-11 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −14 047 53 057 −20,93 13,33 −187 247 707 250
2018-12-12 2018-12-10 4 CDLX Cardlytics, Inc.
Performance Stock Unit
M - Exercise −75 000 0 −100,00
2018-12-12 2018-12-10 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −13 100 67 104 −16,33 13,69 −179 339 918 654
2018-12-12 2018-12-10 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 75 000 80 204 1 441,20
2018-12-07 2018-12-05 4 CDLX Cardlytics, Inc.
Performance Stock Unit
A - Award 75 000 75 000
2018-08-21 2018-08-17 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale −1 198 4 161 −22,35 20,66 −24 751 85 966
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock
C - Conversion −3 859 0 −100,00
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock
M - Exercise 1 193 3 859 44,75
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Restricted Stock Unit
M - Exercise −1 193 0 −100,00
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock
M - Exercise 2 045 2 666 329,31
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Restricted Stock Unit
M - Exercise −2 045 0 −100,00
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock
M - Exercise 621 621
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Restricted Stock Unit
M - Exercise −621 0 −100,00
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Common Stock
P - Purchase 1 500 5 359 38,87 13,00 19 500 69 667
2018-02-15 2018-02-13 4 CDLX Cardlytics, Inc.
Common Stock
C - Conversion 3 859 3 859
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)